BODY & FACE
ONE MOLECULE.
TWO FORMULATIONS.
SEVEN AREAS.
BODY COLLAGEN · LANLUMA X · 630 MG PLLA PER VIAL
BUILT FOR THE PLACES
LIFE SHOWS UP.
Post-postpartum, post-weight-loss, post-menopause, or just over time.
Body Collagen is the high-load formulation — 630 mg of PLLA per vial, built so each session delivers more biostimulation across the larger areas that need it.
BUTTOCKS
THIGHS
UPPER ARMS
Indications and treatment areas may vary by country; always refer to the locally approved product information.
FACE COLLAGEN · LANLUMA V · 210 MG PLLA PER VIAL
THE FACE YOU BROUGHT,
IN THE VERSION YOU WANT NEXT.
Lanluma V is the precision formulation, dosed for the smaller areas of the face and the structure they have — gradually, in your skin, looking like you.
MID-FACE
JAWLINE
TEMPLES
Indications and treatment areas may vary by country; always refer to the locally approved product information.
NASOLABIAL FOLDS
BUTTOCKS· LANLUMA X · BASELINE / 24 MONTHS
AFTER
Treatment done by Dr Giovanni Salti
1 vials of Lanluma X per buttock per session
2 sessions. 1 session every 3 months
UPPER ARMS · LANLUMA V · BASELINE / 8 MONTHS
BEFORE
AFTER
Treatment done by Dr Beatriz Beltran
2 vials of Lanluma V: 1 vial in each arm
3 sessions. 1 session every 2 months
BUTTOCKS · LANLUMA X · BASELINE / 12 MONTHS
AFTER
Treatment done by Dr Francesca de Angelis
10 ml per side. Double dilution
3 sessions
THIGHS · LANLUMA V · BASELINE / 8 MONTHS
BEFORE
BEFORE
BEFORE
AFTER
Treatment done by Dr Beatriz Beltran
2 vials of Lanluma V per session
3 sessions. 1 session every 2 months
BUTTOCKS · LANLUMA X · BASELINE / 6 MONTHS
AFTER
Treatment done by Dr Beatriz Beltran
2 vials of Lanluma X, one per buttock per session
3 sessions. 1 session per month
FACES · LANLUMA V · BASELINE / 12 MONTHS
AFTER
Treatment done by Dr Francesca de Angelis
18 ml (Standard dilution of 15 ml + 3 ml Lidocaine)
1 sessions
Actual patient. Individual effects may vary. Treatment duration depends on the variant used, practitioner‘s technique, patient’s lifestyle and metabolic rate. Lanluma is intended to be administered via injection by a trained and authorised health professional. Opinions and methods presented here are the physician‘s experience. Refer to instructions for details of specific indications
BEFORE
BEFORE
SEE THE RESULTS.
PROGRESSIVE SUPPORT. BETTER WITH TIME.
EVERY DROP, WORKING IN YOU
MORE OF THE DOSE WORKS.
Lanluma is formulated so 87–91% of PLLA concentration is retained from reconstitution through injection — supporting your specialist's protocol.*
* Sinclair R&D data on file (suspension stability; 87–91% PLLA concentration retained during preparation and injection).